PTC THERAPEUTICS, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 36.92 USD | -1.98% |
|
-0.41% | +33.45% |
| May. 24 | Ptc Therapeutics Insider Sold Shares Worth $764,800, According to a Recent SEC Filing | MT |
| May. 21 | Goldman Sachs Adjusts PTC Therapeutics Price Target to $32 From $18, Maintains Sell Rating | MT |
Chart calendar PTC Therapeutics, Inc.
b67cb3c582966bce4b781f07c4f3e2._ZP7Nh48mKDkj7hurey7eRmJqg9onCieo7tj7dAJPOs.u6aMclVM9cqowtJD2sHXGin-wDxapEPc2cIBiOFICpyS3654VAnXy9fLjA~da9947d57673b7555b676237babc9ef9
Upcoming events on PTC Therapeutics, Inc.
Past events on PTC Therapeutics, Inc.
| 2024-06-04 09:00 am | William Blair Growth Stock Conference |
| 2024-05-16 11:40 am | BofA Securities Health Care Conference |
| 2024-05-14 11:00 am | RBC Capital Markets Global Healthcare Conference |
| 2024-04-25 04:30 pm | Q1 2024 Earnings Call |
| 2024-04-25 04:05 pm | Q1 2024 Earnings Release |
| 2024-03-12 04:05 pm | Barclays Global Healthcare Conference |
| 2024-03-11 02:40 pm | Leerink Partners Global Biopharma Conference |
| 2024-03-04 01:30 pm | TD Cowen Health Care Conference |
| 2024-02-29 04:30 pm | Q4 2023 Earnings Call |
| 2024-02-29 04:05 pm | Q4 2023 Earnings Release |
| 2024-01-08 10:30 am | JPMorgan Healthcare Conference |
| 2023-10-26 04:30 pm | Q3 2023 Earnings Call |
| 2023-10-26 04:05 pm | Q3 2023 Earnings Release |
| 2023-09-15 08:45 am | Business Update Call |
| 2023-09-11 01:35 pm | Morgan Stanley Global Healthcare Conference |
| 2023-09-06 09:40 am | Citi BioPharma Conference |
| 2023-08-31 05:30 am | Society for the Study of Inborn Errors of Metabolism Symposium |
| 2023-08-03 04:30 pm | Q2 2023 Earnings Call |
| 2023-08-03 04:01 pm | Q2 2023 Earnings Release |
| 2023-07-19 12:00 pm | Business Update Call |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 307 305 0.49% | 381 376 1.26% | 539 536 0.57% | 699 710 -1.59% | 938 946 -0.82% | 760 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 -159 - | -283 -328 13.94% | -310 -323 3.78% | -319 -236 -35.13% | -203 -101 -100.55% | -43,4 |
|
EBIT Million USD | Released Forecast Spread | -241 -170 -42.21% | -326 -377 13.5% | -374 -377 0.72% | -447 -336 -33.35% | -440 -324 -35.6% | -216 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -240 -183 -31.26% | -403 -378 -6.58% | -518 -498 -4.16% | -587 -512 -14.68% | -696 -480 -44.94% | -393 |
|
Net income Million USD | Released Forecast Spread | -252 -190 -32.22% | -438 -418 -4.9% | -524 -503 -4.21% | -559 -504 -10.94% | -627 -422 -48.43% | -385 |
|
EPS USD | Released Forecast Spread | -4,27 -3,35 -27.31% | -6,64 -6,30 -5.43% | -7,43 -6,70 -10.96% | -7,79 -6,94 -12.27% | -8,37 -5,65 -48.19% | -5,03 |
| Announcement Date | 02/03/20 | 25/02/21 | 22/02/22 | 21/02/23 | 29/02/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 149 147 1.25% | 166 163 1.84% | 217 185 17.42% | 167 183 -8.55% | 220 200 9.93% | 214 206 3.82% | 197 212 -7.15% | 307 318 -3.54% | 210 164 28.26% | 187 | 170 | 199 | 135 | 198 |
|
EBITDA Million USD | Released Forecast Spread | -60,2 -40,8 -47.5% | -74,8 -129 42.02% | -159 -208 23.78% | 86,5 66,0 31.1% | ||||||||||
|
EBIT Million USD | Released Forecast Spread | -86,5 -92,5 6.44% | -92,4 -77,6 -19.07% | -68,2 -72,7 6.2% | -200 -94,6 -111.68% | -118 -95,0 -23.84% | -210 -102 -106.29% | -118 -55,5 -112.88% | 5,82 85,8 -93.22% | -45,5 -73,5 38.13% | -50,9 | -76,2 | -41,5 | -41,1 | 22,8 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -122 -109 -11.98% | -149 -109 -36.77% | -127 -99,4 -27.95% | -190 -108 -75.03% | -135 -123 -9.58% | -237 -126 -88.81% | -167 -61,4 -171.37% | -157 19,7 -896.37% | -84,7 -97,6 13.2% | -88,4 | -119 | -101 | ||
|
Net income Million USD | Released Forecast Spread | -127 -108 -17.22% | -152 -103 -47.54% | -109 -98,6 -10.91% | -171 -116 -47.73% | -139 -123 -13.41% | -199 -123 -61.21% | -133 -68,8 -93.4% | -156 32,8 -574.79% | -91,6 -93,1 1.65% | -86,2 | -112 | -96,5 | -39,3 | -7,70 |
|
EPS USD | Released Forecast Spread | -1,78 -1,51 -17.65% | -2,13 -1,37 -55.65% | -1,53 -1,29 -18.37% | -2,35 -1,57 -49.56% | -1,88 -1,49 -25.96% | -2,66 -1,62 -64.02% | -1,76 -1,06 -65.26% | -2,06 0,41 -597.09% | -1,20 -1,27 5.38% | -1,07 | -1,46 | -1,42 | -1,13 | -0,66 |
| Announcement Date | 03/05/22 | 04/08/22 | 27/10/22 | 21/02/23 | 27/04/23 | 03/08/23 | 26/10/23 | 29/02/24 | 25/04/24 | - | - | - | - | - |
More events
Past sector events for PTC Therapeutics, Inc.
| 2024-06-05 03:51 am | PHARMAESSENTIA CORPORATION: May 2024 Sales and Revenue Release |
| 2024-05-17 07:00 am | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
| 2024-05-16 07:46 am | BIOCON LIMITED: Q4 2024 Earnings Release |
| 2024-05-16 01:00 am | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
| 2024-05-15 | LIGACHEM BIOSCIENCES INC.: Q1 2024 Earnings Release |
| 2024-05-15 08:05 am | THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release |
| 2024-05-15 07:00 am | CABALETTA BIO, INC.: Q1 2024 Earnings Release |
| 2024-05-14 | TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release |
| 2024-05-14 04:05 pm | ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-14 04:00 pm | ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- PTCT Stock
- Calendar PTC Therapeutics, Inc.
